95MO Circulating tumor DNA (ctDNA) dynamics in patients (pts) receiving capecitabine (CAPE) for early-stage triple-negative breast cancer (eTNBC) with an incomplete response to neoadjuvant therapy (NAT)
Titel:
95MO Circulating tumor DNA (ctDNA) dynamics in patients (pts) receiving capecitabine (CAPE) for early-stage triple-negative breast cancer (eTNBC) with an incomplete response to neoadjuvant therapy (NAT)
Auteur:
Gupta, T. Garcia, C. Biederman, S. Kalashnikova, E. Rodriguez, A.A. Liu, M.C. Keenan, J. Medford, A.J. Isakoff, S. Bardia, A. Telli, M.L. Ho, A.Y.